ISSN: 1574-8898

Journal Home

Journal Guideline

Recent Patents on CNS Drug Discovery Q4 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Recent Patents on CNS Drug Discovery is a journal indexed in SJR in Drug Discovery and Psychiatry and Mental Health with an H index of 32. It has a best quartile of Q4.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q4) Pharmacology (medical) (Q4) Psychiatry and Mental Health (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

-

SJR Impact factor

32

H Index

0

Total Docs (Last Year)

18

Total Docs (3 years)

0

Total Refs

10

Total Cites (3 years)

17

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Natural Product Sciences Q4
Pharmaceutical Chemistry Journal Q4
Expert Review of Precision Medicine and Drug Development Q4
International Journal of Computational Biology and Drug Design Q4
Current Enzyme Inhibition Q4

Compare this journals

Aims and Scope

Best articles by citations

Potential Drugs and Methods for Preventing or Delaying the Progression of Huntington's Disease

Translating Genetic Findings into Therapy in Parkinson Disease

Novel Molecular Targets for the Prevention of Fetal Alcohol Syndrome

Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

Antisense Oligonucleotides in the Treatment of Cerebral Gliomas. Review of Concerning Patents

Editorial

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

Drugs and Aggression

Scientific Prediction and Prophetic Patenting in Drug Discovery

Multitasking of Neuropeptide Y through the Lens of Motifs

Future Targeted Disease Modifying Drugs for Alzheimer's Disease

Current Options in the Treatment of Mitochondrial Diseases

SHOW MORE ARTICLES

Rho-ROCK Inhibitors for the Treatment of CNS Injury

The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders

Author Index To Volume 1

Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers

The Seek of Neuroprotection: Introducing Cannabinoids

Neurodegeneration and Neuroprotective Agents in Multiple Sclerosis

BACE Inhibitors as Potential Therapeutics for Alzheimers disease

Meet Our Editorial Board Member Dr. Vittorio Gentile

Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins

Role of Dietary Polyphenols in Attenuating Brain Edema and Cell Swelling in Cerebral Ischemia

Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation

Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders

Recent Patents on CNS Drug Discovery Q4 Unclaimed

- €

NPD

- €

Metrics

-

32

0

18

0

10

17

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Recent Patents on CNS Drug Discovery?